Arcturus Therapeutics Holdings (ARCT) Current Assets (2018 - 2026)

Arcturus Therapeutics Holdings' Current Assets history runs 9 years deep, the most recent figure standing at $216.9 million for Q1 2026.

• Quarterly Current Assets fell 22.21% year-over-year to $216.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $216.9 million (down 22.21% YoY) and the FY2025 annual result came in at $241.4 million, down 21.09% from the prior year.
• Current Assets was $216.9 million for Q1 2026 at Arcturus Therapeutics Holdings, down from $241.4 million in the prior quarter.
• Across five years, Current Assets topped out at $424.6 million in Q1 2023 and bottomed at $216.9 million in Q1 2026.
• A 5-year average of $322.3 million and a median of $327.0 million in 2022 frame the typical range for Current Assets.
• Annual changes were most pronounced in 2022 — Current Assets plunged 41.4% — and 2023, when it soared 59.42%.
• Arcturus Therapeutics Holdings' Current Assets stood at $403.3 million in 2022, then fell by 4.15% to $386.6 million in 2023, then fell by 20.85% to $306.0 million in 2024, then declined by 21.09% to $241.4 million in 2025, then decreased by 10.17% to $216.9 million in 2026.
• Business Quant data shows ARCT's Current Assets at $216.9 million in Q1 2026, $241.4 million in Q4 2025, and $249.2 million in Q3 2025.